470 related articles for article (PubMed ID: 25295846)
1. Influence of copolymer composition on the phase behavior of solid dispersions.
Prudic A; Kleetz T; Korf M; Ji Y; Sadowski G
Mol Pharm; 2014 Nov; 11(11):4189-98. PubMed ID: 25295846
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Physical Stability of PVP- and PVPVA-Amorphous Solid Dispersions.
Lehmkemper K; Kyeremateng SO; Heinzerling O; Degenhardt M; Sadowski G
Mol Pharm; 2017 Jan; 14(1):157-171. PubMed ID: 28043133
[TBL] [Abstract][Full Text] [Related]
3. Influence of Low-Molecular-Weight Excipients on the Phase Behavior of PVPVA64 Amorphous Solid Dispersions.
Lehmkemper K; Kyeremateng SO; Degenhardt M; Sadowski G
Pharm Res; 2018 Jan; 35(1):25. PubMed ID: 29305717
[TBL] [Abstract][Full Text] [Related]
4. Physical stability of API/polymer-blend amorphous solid dispersions.
Lehmkemper K; Kyeremateng SO; Bartels M; Degenhardt M; Sadowski G
Eur J Pharm Biopharm; 2018 Mar; 124():147-157. PubMed ID: 29269154
[TBL] [Abstract][Full Text] [Related]
5. A Novel Approach for Analyzing the Dissolution Mechanism of Solid Dispersions.
Ji Y; Paus R; Prudic A; Lübbert C; Sadowski G
Pharm Res; 2015 Aug; 32(8):2559-78. PubMed ID: 25715696
[TBL] [Abstract][Full Text] [Related]
6. Influence of humidity on the phase behavior of API/polymer formulations.
Prudic A; Ji Y; Luebbert C; Sadowski G
Eur J Pharm Biopharm; 2015 Aug; 94():352-62. PubMed ID: 26117187
[TBL] [Abstract][Full Text] [Related]
7. Thermodynamic phase behavior of API/polymer solid dispersions.
Prudic A; Ji Y; Sadowski G
Mol Pharm; 2014 Jul; 11(7):2294-304. PubMed ID: 24870944
[TBL] [Abstract][Full Text] [Related]
8. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
Caron V; Tajber L; Corrigan OI; Healy AM
Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
[TBL] [Abstract][Full Text] [Related]
9. Influence of excipients on solubility and dissolution of pharmaceuticals.
Paus R; Prudic A; Ji Y
Int J Pharm; 2015 May; 485(1-2):277-87. PubMed ID: 25749073
[TBL] [Abstract][Full Text] [Related]
10. Impact of Polymer Type and Relative Humidity on the Long-Term Physical Stability of Amorphous Solid Dispersions.
Lehmkemper K; Kyeremateng SO; Heinzerling O; Degenhardt M; Sadowski G
Mol Pharm; 2017 Dec; 14(12):4374-4386. PubMed ID: 29050468
[TBL] [Abstract][Full Text] [Related]
11. Mutual Impact of Phase Separation/Crystallization and Water Sorption in Amorphous Solid Dispersions.
Luebbert C; Wessner M; Sadowski G
Mol Pharm; 2018 Feb; 15(2):669-678. PubMed ID: 29309155
[TBL] [Abstract][Full Text] [Related]
12. Thermodynamic phase behaviour of indomethacin/PLGA formulations.
Prudic A; Lesniak AK; Ji Y; Sadowski G
Eur J Pharm Biopharm; 2015 Jun; 93():88-94. PubMed ID: 25791211
[TBL] [Abstract][Full Text] [Related]
13. Solubility of crystalline organic compounds in high and low molecular weight amorphous matrices above and below the glass transition by zero enthalpy extrapolation.
Amharar Y; Curtin V; Gallagher KH; Healy AM
Int J Pharm; 2014 Sep; 472(1-2):241-7. PubMed ID: 24968139
[TBL] [Abstract][Full Text] [Related]
14. Phase behavior of pharmaceutically relevant polymer/solvent mixtures.
Dohrn S; Luebbert C; Lehmkemper K; Kyeremateng SO; Degenhardt M; Sadowski G
Int J Pharm; 2020 Mar; 577():119065. PubMed ID: 31988034
[TBL] [Abstract][Full Text] [Related]
15. Investigation of Ethylene Oxide-co-propylene Oxide for Dissolution Enhancement of Hot-Melt Extruded Solid Dispersions.
Hurley D; Potter CB; Walker GM; Higginbotham CL
J Pharm Sci; 2018 May; 107(5):1372-1382. PubMed ID: 29410037
[TBL] [Abstract][Full Text] [Related]
16. Micro-scale solubility assessments and prediction models for active pharmaceutical ingredients in polymeric matrices.
Bochmann ES; Neumann D; Gryczke A; Wagner KG
Eur J Pharm Biopharm; 2019 Aug; 141():111-120. PubMed ID: 31100430
[TBL] [Abstract][Full Text] [Related]
17. Amorphous-Amorphous Phase Separation in API/Polymer Formulations.
Luebbert C; Huxoll F; Sadowski G
Molecules; 2017 Feb; 22(2):. PubMed ID: 28212300
[TBL] [Abstract][Full Text] [Related]
18. Influence of PVP/VA copolymer composition on drug-polymer solubility.
Rask MB; Knopp MM; Olesen NE; Holm R; Rades T
Eur J Pharm Sci; 2016 Mar; 85():10-7. PubMed ID: 26826280
[TBL] [Abstract][Full Text] [Related]
19. Investigation of miscibility estimation methods between indomethacin and poly(vinylpyrrolidone-co-vinyl acetate).
Pezzoli R; Lyons JG; Gately N; Higginbotham CL
Int J Pharm; 2018 Oct; 549(1-2):50-57. PubMed ID: 30016675
[TBL] [Abstract][Full Text] [Related]
20. Comparative Study of DSC-Based Protocols for API-Polymer Solubility Determination.
Mathers A; Hassouna F; Klajmon M; Fulem M
Mol Pharm; 2021 Apr; 18(4):1742-1757. PubMed ID: 33656884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
